Atezolizumab vs Dabigatran

## Atezolizumab vs Dabigatran: Overview

This comparison examines the pharmacological differences between **Atezolizumab** and **Dabigatran**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

**Dabigatran**: Direct thrombin (Factor IIa) inhibitor.

## Pharmacokinetics

**Half-life**: Atezolizumab — 27 days; Dabigatran — 12-17 hours.

## Chemical Properties

**Molecular Formula**: Atezolizumab — N/A; Dabigatran — C25H25N7O3.

**Molecular Weight**: Atezolizumab — N/A; Dabigatran — 471.5100 g/mol.

**Type**: Atezolizumab — Antibody; Dabigatran — Small molecule.